Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Current Deferred Revenue (2016 - 2025)

Natural Health Trends' Current Deferred Revenue history spans 16 years, with the latest figure at $5.6 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 13.76% year-over-year to $5.6 million; the TTM value through Dec 2025 reached $5.6 million, up 13.76%, while the annual FY2025 figure was $5.6 million, 13.76% up from the prior year.
  • Current Deferred Revenue reached $5.6 million in Q4 2025 per NHTC's latest filing, up from $4.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $7.6 million in Q2 2024 to a low of $3.8 million in Q4 2022.
  • Average Current Deferred Revenue over 5 years is $5.3 million, with a median of $5.3 million recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: surged 115.99% in 2021, then tumbled 41.54% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $6.5 million in 2021, then crashed by 41.54% to $3.8 million in 2022, then rose by 15.79% to $4.4 million in 2023, then grew by 11.36% to $4.9 million in 2024, then increased by 13.76% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for NHTC's Current Deferred Revenue are $5.6 million (Q4 2025), $4.5 million (Q3 2025), and $4.6 million (Q2 2025).